The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Linking β-Catenin to Androgen-signaling Pathway
Open accessAbstract
The androgen-signaling pathway is important for the growth and progression of prostate cancer cells. The growth-promoting effects of androgen on prostate cells are mediated mostly through the androgen receptor (AR). There is increasing evidence that transcription activation by AR is mediated through interaction with other cofactors. beta-Catenin plays a critical role in embryonic development and tumorigenesis through its effects on E-cadherin-mediated cell adhesion and Wnt-dependent signal transduction. Here, we demonstrate that a specific protein-protein interaction occurs between beta-catenin and AR. Unlike the steroid hormone receptor coactivator 1 (SRC1), beta-catenin showed a strong interaction with AR but not with other steroid hormone receptors such as estrogen receptor alpha, progesterone receptor beta, and glucocorticoid receptor. The ligand binding domain of AR and the NH(2) terminus combined with the first six armadillo repeats of beta-catenin were shown to be necessary for the interaction. Through this specific interaction, beta-catenin augments the ligand-dependent activity of AR in prostate cancer cells. Moreover, expression of E-cadherin in E-cadherin-negative prostate cancer cells results in redistribution of the cytoplasmic beta-catenin to the cell membrane and reduction of AR-mediated transcription. These data suggest that loss of E-cadherin can elevate the cellular levels of beta-catenin in prostate cancer cells, which may directly contribute to invasiveness and a more malignant tumor phenotype by augmenting AR activity during prostate cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While FKBP52 is known to functionally interact with AR, GR and PR [6–8], β-catenin only interacts strongly with AR, but not GR and PR [20].”
From The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling (2015) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Landis, S., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P. M., Halladay, J. T., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,638
β‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Flagged first, then by citations
Research works printed but not linked: 12
- Jenster, 1999, Semin. Oncol., 26, 407
- Gayther, 1998, Cancer Res., 58, 4086
- Richmond, 1997, Cancer Res., 57, 3189
- Sasaki, 2000, Cancer Res., 60, 7057
- Truica, 2000, Cancer Res., 60, 4709
- Shibata, 1997, Recent Prog. Horm. Res., 52, 141
- Pang, 1997, Cancer Res., 57, 495
- Birchmeier, 1995, Cancer Surv., 24, 129
- Umbas, 1992, Cancer Res., 52, 5104
- Graff, 1995, Cancer Res., 55, 5195
- Voeller, 1998, Cancer Res., 58, 2520
- van de Wetering, 2001, Cancer Res., 61, 278
Cited by
Sorted by citations
Items 101–200 of 342
Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P. G., Cheng, C., Dai, H. A., Freedman, L. P., & Ray, W. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0048 · Cited by 75
Solid Pseudopapillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma
Naar, L., Spanomichou, D., Mastoraki, A. T., Smyrniotis, V. E., & Arkadopoulos, N. F. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-3921-y · Cited by 80
Goldstein, A. S., Stoyanova, T. I., & Witte, O. N. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.009 · Cited by 75
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
Schweizer, M. T., & Yu, E. Y. (2017) · Cancers · doi:10.3390/cancers9010007 · Cited by 75
Protein Kinase D1–Mediated Phosphorylation and Subcellular Localization of β-Catenin
Du, C., Jaggi, M., Zhang, C., & Balaji, K. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6270 · Cited by 73
Persistent androgen receptor addiction in castration-resistant prostate cancer
Schweizer, M. T., & Yu, E. Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0225-2 · Cited by 77
Wnt signaling in castration-resistant prostate cancer: implications for therapy.
Yokoyama, N. N., Shao, S., Hoang, B. H., Mercola, D., & Zi, X. (2014) · PubMed Central · Cited by 73
Kennell, J. A., O’Leary, E. E., Gummow, B. M., Hammer, G. D., & MacDougald, O. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5366-5375.2003 · Cited by 73
Fanelli, M. A., Guevara, M. M. M., Diblasi, Á. M., Gago, F. E., Tello, O. M., Cuello-Carrión, F. D., Callegari, E. A., Bausero, M. A., & Ciocca, D. R. (2008) · Cell Stress and Chaperones · doi:10.1007/s12192-007-0007-z · Cited by 72
Chen, S., Wulf, G. M., Zhou, X. Z., Rubin, M. A., Lu, K. P., & Balk, S. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.929-939.2006 · Cited by 72
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Joshi, M. D., Ahmad, R., Li, Y., Raina, D. B., Rajabi, H. N., Bubley, G. J., Kharbanda, S. M., & Kufe, D. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0646 · Cited by 70
Wright, M. E., Eng, J. K., Sherman, J., Hockenbery, D. M., Nelson, P. S., Galitski, T., & Aebersold, R. H. (2003) · Genome biology · doi:10.1186/gb-2003-5-1-r4 · Cited by 72
Chesire, D. R., Dunn, T. A., Ewing, C. M., Luo, J., & Isaacs, W. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3309 · Cited by 73
Synergistic Effects of Coactivators GRIP1 and β-Catenin on Gene Activation
Li, H., Kim, J. H., Koh, S. S., & Stallcup, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311374200 · Cited by 70
Antony, L., van der Schoor, F., Dalrymple, S. L., & Isaacs, J. T. (2014) · The Prostate · doi:10.1002/pros.22828 · Cited by 69
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
Elshan, N. G. R. D., Rettig, M. B., & Jung, M. E. (2018) · Medicinal Research Reviews · doi:10.1002/med.21548 · Cited by 69
Jeong, B., Hong, C. Y., Chattopadhyay, S., Park, J., Gong, E., Kim, H., Chun, S., & Lee, K. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0065 · Cited by 67
Androgen activates β-catenin signaling in bladder cancer cells
Li, Y., Zheng, Y., Izumi, K., Ishiguro, H., Ye, B., Li, F., & Miyamoto, H. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0328 · Cited by 67
Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
Zheng, D., Decker, K. F., Zhou, T., Chen, J., Qi, Z., Jacobs, K., Weilbaecher, K. N., Corey, E., Long, F., & Li, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0520 · Cited by 69
Endocrine Disruptors and Prostate Cancer
Corti, M., Lorenzetti, S., Ubaldi, A., Zilli, R., & Marcoccia, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031216 · Cited by 66
A Mouse Model of Androgenetic Alopecia
Crabtree, J. S., Kilbourne, E. J., Peano, B. J., Chippari, S. M., Kenney, T. F., McNally, C., Wang, W., Harris, H. A., Winneker, R. C., Nagpal, S., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1474 · Cited by 66
Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
Abdin, R., Zhang, Y., & Jimenez, J. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.843127 · Cited by 75
Liu, X., Allen, J. D., Arnold, J. T., & Blackman, M. R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn011 · Cited by 65
Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis
Xiong, W., Zhang, L., Yu, L., Xie, W., Man, Y., Xiong, Y., Liu, H., & Liu, Y. (2015) · Reproduction · doi:10.1530/rep-15-0371 · Cited by 64
Pak, S., Park, S., Kim, Y., Park, J., Park, C. H., Lee, K.-J., Kim, C., & Ahn, H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1342-5 · Cited by 65
Structural basis of coactivation of liver receptor homolog-1 by β-catenin
Yumoto, F., Nguyen, P., Sablin, E. P., Baxter, J. D., Webb, P., & Fletterick, R. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117036108 · Cited by 63
Roy, L., McDonald, C. A., Jiang, C. Q., Maroni, D. M., Zeleznik, A. J., Wyatt, T. A., Hou, X., & Davis, J. S. (2009) · Endocrinology · doi:10.1210/en.2009-0771 · Cited by 63
Lee, G. T., Kang, D. I., Ha, Y.-S., Jung, Y. S., Chung, J. M., Min, K. S., Kim, T. H., Moon, K. H., Chung, J. M., Lee, D. H., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.23 · Cited by 62
The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-β-Catenin Complex
Takayama, S., Rogatsky, I., Schwarcz, L. E., & Darimont, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602290200 · Cited by 62
Androgen regulation of the androgen receptor coregulators
Urbanucci, A., Waltering, K. K., Suikki, H. E., Helenius, M. A., & Visakorpi, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-219 · Cited by 62
Verras, M., & Sun, Z. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0208 · Cited by 64
Self-citationEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer
Sabatino, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7137 · Cited by 61
Morrissey, C. M., Brown, L. G., Pitts, T. E. M., Vessella, R. L., & Corey, E. (2010) · Neoplasia · doi:10.1593/neo.91836 · Cited by 61
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link
D’Errico, I., & Moschetta, A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7552-1 · Cited by 62
Coordinated Action of Hypoxia-inducible Factor-1α and β-Catenin in Androgen Receptor Signaling
Mitani, T., Harada, N., Nakano, Y., Inui, H., & Yamaji, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388298 · Cited by 60
Constitutive β-Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium
Lin, C., Yin, Y., Stemler, K. M., Humphrey, P. A., Kibel, A. S., Mysorekar, I. U., & Ma, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4198 · Cited by 60
Welcoming β-Catenin to the Gonadotropin-Releasing Hormone Transcriptional Network in Gonadotropes
Salisbury, T. B., Binder, A. K., & Nilson, J. H. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0515 · Cited by 60
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
Horvath, L. G., Henshall, S. M., Lee, C. S., Kench, J. G., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., Grygiel, J. J., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20599 · Cited by 58
Wnt signaling: the good and the bad
Chen, X., Yang, J., Evans, P. M., & Liu, C. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00440.x · Cited by 56
Ramayo‐Caldas, Y., Ballester, M., Fortes, M. R. S., Esteve‐Codina, A., Castelló, A., Noguera, J. L., Fernández, A. I., Miguel Pérez-enciso, A., Reverter, A., & Folch, J. M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-232 · Cited by 61
Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer
Kominea, A., Konstantinopoulos, P. A., Kapranos, N., Vandoros, G. P., Gkermpesi, M., Andricopoulos, P., Artelaris, S., Savva, S., Varakis, I., Sotiropoulou‐Bonikou, G., et al. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0531-x · Cited by 57
Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance
Wang, C., Chen, Q., & Xu, H. (2021) · Discover Oncology · doi:10.1007/s12672-021-00433-6 · Cited by 56
Prostatic preneoplasia and beyond
Joshua, A. M., Evans, A., van der Kwast, T., Zieleńska, M., Meeker, A. K., Chinnaiyan, A. M., & Squire, J. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.12.001 · Cited by 62
Horvath, L. G., Lelliott, J. E., Kench, J. G., Lee, C. S., Williams, E. D., Saunders, D. N., Grygiel, J. J., Sutherland, R. L., & Henshall, S. M. (2007) · The Prostate · doi:10.1002/pros.20607 · Cited by 56
Kasai, M., Guerrero‐Santoro, J., Friedman, R. L., Leman, E. S., Getzenberg, R. H., & DeFranco, D. B. (2003) · PubMed · Cited by 56
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
Li, T.-H., Zhao, H., Peng, Y., Beliakoff, J., Brooks, J. D., & Sun, Z. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm198 · Cited by 53
Self-citationMutations in the AXIN1 Gene in Advanced Prostate Cancer
Yardy, G., Bicknell, D., Wilding, J. L., Bartlett, S., Liu, Y., WINNEY, B. J., Turner, G. D. H., BREWSTER, S. F., & Bodmer, W. F. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.029 · Cited by 52
MUC1‐C oncoprotein confers androgen‐independent growth of human prostate cancer cells
Rajabi, H. N., Ahmad, R., Jin, C., Joshi, M. D., Guha, M., Alam, M., Kharbanda, S. M., & Kufe, D. W. (2012) · The Prostate · doi:10.1002/pros.22519 · Cited by 51
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Pakula, H., Xiang, D., & Li, Z. (2017) · Cancers · doi:10.3390/cancers9020014 · Cited by 55
Lgr4-mediated Wnt/β-catenin signaling in peritubular myoid cells is essential for spermatogenesis
Yu, Q., Liu, S., Guan, Y., Pan, H., Guan, X., Qiu, Z., Li, L., Gao, N., Zhao, Y., Li, X., et al. (2013) · Development · doi:10.1242/dev.093641 · Cited by 51
Self-citationInteraction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor
Song, L., & Gelmann, E. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503850200 · Cited by 51
HIC-5 Is a Novel Repressor of Lymphoid Enhancer Factor/T-cell Factor-driven Transcription
Ghogomu, S. M., van Venrooy, S., Ritthaler, M., Wedlich, D., & Gradl, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505869200 · Cited by 49
Mizutani, K., Miyamoto, S., Nagahata, T., Konishi, N., Emi, M., & Onda, M. (2005) · Tumori Journal · doi:10.1177/030089160509100616 · Cited by 48
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Koushyar, S., Méniel, V. S., Phesse, T. J., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom12020309 · Cited by 48
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
Wang, Y., Singhal, U., Qiao, Y., Kasputis, T., Chung, J., Zhao, H., Chammaa, F., Belardo, J. A., Roth, T. M., Zhang, H., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100747 · Cited by 47
Inappropriate activation of androgen receptor by relaxin via β-catenin pathway
Liu, S., Vinall, R. L., Tepper, C. G., Shi, X.-B., Xue, L. R., Ma, A.-H., Wang, L.-Y., Fitzgerald, L. D., Wu, Z., Gandour‐Edwards, R. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210671 · Cited by 47
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
Anestis, A., Karamouzis, M. V., Dalagiorgou, G., & Papavassiliou, A. G. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.04.009 · Cited by 46
Ali, M. K., Shahin, S. M., Sabri, N. A., Al-Hendy, A. A., & Yang, Q. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz227 · Cited by 45
Glycogen synthase kinase-3: A potential preventive target for prostate cancer management
Li, B., Thrasher, J. B., & Terranova, P. F. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.05.006 · Cited by 45
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 48
Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma
Sauer, C. G., Roemer, A., & Grobholz, R. (2005) · The Prostate · doi:10.1002/pros.20338 · Cited by 45
GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy
Duran, J., Oyarce, C., Pávez, M., Valladares-Ide, D., Basualto-Alarcón, C., Lagos, D., Barrientos, G. C., Troncoso, M. F., Ibarra, C., & Estrada, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168255 · Cited by 44
Pan, Y., Zhang, J., Gazi, M. H., & Young, C. Y. F. (2003) · PubMed · Cited by 44
Kawano, Y., Diez, S., Onganer, P. U., Darrington, R. S., Waxman, J., & Kypta, R. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604976 · Cited by 44
Jung, S. J., Oh, S., Lee, G. T., Chung, J., Min, K. S., Yoon, J., Kim, W., Ryu, D. S., Kim, I. Y., & Kang, D. I. (2013) · The World Journal of Men s Health · doi:10.5534/wjmh.2013.31.1.36 · Cited by 43
When prostate cancer meets bone: Control by wnts
Emami, K. H., & Corey, E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.040 · Cited by 42
Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights
Yuan, Y., Wu, D., Hou, Y., Zhang, Y., Tan, C., Nie, X., Zhao, Z., & Hou, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116154 · Cited by 42
Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours
Karim, R. Z., Scolyer, R. A., Tse, G. M.-K., Tan, P., Putti, T. C., & Lee, C. S. (2009) · Pathology · doi:10.1080/00313020802579342 · Cited by 41
Lo, Y., Noah, T. K., Chen, M.-S., Zou, W. Y., Borràs, E., Vilar, E., & Shroyer, N. F. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.048 · Cited by 41
Liu, X., Wu, Y., Yao, S., Levine, A. C., Kirschenbaum, A. M., Collier, L., Bauman, W. A., & Cardozo, C. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478487 · Cited by 40
WNT SIGNALING IN PROSTATE DEVELOPMENT AND CARCINOGENESIS
Kharaishvili, G., Šimková, D., Makharoblidze, E., Trtková, K. S., Kolář, Z., & Bouchal, J. (2011) · Biomedical Papers · doi:10.5507/bp.2011.016 · Cited by 40
Li, K., Mao, Y., Li, L., Hu, C., Wang, D., Situ, J., Lu, M., Peng, S., Qiu, J., & Gao, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3671 · Cited by 40
Olson, A. W., Le, V. L., Aldahl, J., Yu, E., Hooker, E., He, Y., Lee, D.-H., Kim, W. K., Cardiff, R. D., Geradts, J., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008451 · Cited by 41
Self-citationLiu, X., Kirschenbaum, A. M., Shen, Y., Liu, G., Aaronson, S. A., & Levine, A. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0478 · Cited by 40
Androgen receptor regulates expression of the MUC1‐C oncoprotein in human prostate cancer cells
Rajabi, H. N., Joshi, M. D., Jin, C., Ahmad, R., & Kufe, D. W. (2011) · The Prostate · doi:10.1002/pros.21344 · Cited by 39
Mechanism of the Tissue-Specific Action of the Selective Androgen Receptor Modulator S-101479
Furuya, K., Yamamoto, N., Ohyabu, Y., Morikyu, T., Ishige, H., Albers, M., & Endo, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00885 · Cited by 38
Above genetics: Lessons from cerebral development in autism
Williams, E., & Casanova, M. F. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0016-3 · Cited by 38
Salon, C., Moro‐Sibilot, D., Lantuéjoul, S., Brichon, P. Y., Drabkin, H. A., Brambilla, C., & Brambilla, E. M. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.015 · Cited by 37
Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor
Clines, G. A., Mohammad, K. S., Grunda, J. M., Clines, K. L., Niewolna, M., McKenna, C. R., McKibbin, C. R., Yanagisawa, M., Suva, L. J., Chirgwin, J. M., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.450 · Cited by 37
Kong, Y., Poon, R. W. M., Nadesan, P., Muccio, T. D., Fodde, R., Khokha, R., & Alman, B. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3112 · Cited by 36
Song, D., Ji, Y., Huang, X., Ma, Y., Fang, C., Qiu, L., Tan, X., Chen, Y.-L., Wang, S., Chang, J., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13832 · Cited by 33
The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance
Voutsadakis, I. A., & Papandreou, C. N. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.03.013 · Cited by 34
Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis
Lee, S. H., Luong, R. H., Johnson, D. T., Cunha, G. R., Rivina, L., Gonzalgo, M. L., & Sun, Z. (2015) · Oncogene · doi:10.1038/onc.2015.117 · Cited by 33
Self-citationRay, S., Xu, F., Wang, H., & Das, S. K. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0445 · Cited by 33
Markowski, M. C., Marzo, A. M. D., & Antonarakis, E. S. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1393518 · Cited by 33
Mixed Lineage Kinase 3 Modulates β-Catenin Signaling in Cancer Cells
Thylur, R. P., Subramanian, S., Campbell, E. M., Rangasamy, V., Thorenoor, N., Sondarva, G. V., Mehrotra, S., Mishra, P., Zook, E. C., Le, P. T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298943 · Cited by 34
Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling
Qin, W., Zheng, Y., Qian, B., & Zhao, M. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00153 · Cited by 33
Morin, P. J., & Weeraratna, A. T. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_7 · Cited by 34
Androgen receptor epigenetics.
Cai, C., Yuan, X., & Balk, S. P. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-4683.2013.09.02 · Cited by 32
Hong, J. H., Lee, G., & Choi, H. Y. (2015) · Korean journal of urology · doi:10.4111/kju.2015.56.9.656 · Cited by 31
Ma, H., Thapa, A., Morris, L. M., Michalakis, S., Biel, M., Frank, M. B., Bebak, M., & Ding, X. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt245 · Cited by 31
Fonte, C., Grenier, J., Trousson, A., Chauchereau, A., Lahuna, O., Baulieu, É.-É., Schumacher, M., & Massaad, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506930102 · Cited by 31
Spillane, M., Schwarz, N. A., & Willoughby, D. S. (2015) · Steroids · doi:10.1016/j.steroids.2015.02.019 · Cited by 30
Expression of b-Catenin in Prostatic Adenocarcinomas A Comparison With Colorectal Adenocarcinomas
Bismar, T. A., Humphrey, P. A., Grignon, D. J., & Wang, H. L. (2004) · American Journal of Clinical Pathology · doi:10.1309/4470-49gv-52h7-d258 · Cited by 30
Götz, C., Bachmann, C., & Montenarh, M. (2006) · The Prostate · doi:10.1002/pros.20471 · Cited by 30
Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
Nepali, P. R., & Kyprianou, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1160267 · Cited by 27
Lee, S. H., Zhu, C., Yue, P., Johnson, D. T., Lehmann, L. W., & Sun, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529727 · Cited by 28
Self-citationRead, J. T., Rahmani, M., Boroomand, S., Allahverdian, S., McManus, B. M., & Rennie, P. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702099200 · Cited by 28
Role of GAC63 in transcriptional activation mediated by -catenin
Chen, Y., Yang, C.-H., Xia, M., Ou, C. Y., & Stallcup, M. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm095 · Cited by 28
Targeting Prostate Cancer Stem Cells
Crea, F., Mathews, L., Farrar, W. L., & Hurt, E. M. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009789735053 · Cited by 27
Metadata
- Authors
- Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z.
- Affiliations
- Stanford Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- National Institutes of Health (US)
- Corresponding author
- Sun, Zijie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11336-11344
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022810442
- Cited by
- 342
- References
- 54
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 4 · 2020: 10 · 2019: 14 · 2018: 10 · 2017: 19 · 2016: 7 · 2015: 17 · 2014: 12 · 2013: 19 · 2012: 10
- FWCI
- 20.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01dk054417-01)
- National Cancer Institute (CA-70297, R01CA087767, R29CA070297, R01CA070297)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061002, DK54417, R56DK061002, R01DK047636, DK47636)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- β-catenin, androgen receptor, androgen signaling, prostate cancer, protein-protein interaction, E-cadherin, Wnt signaling, armadillo repeats, transcriptional coactivation, steroid hormone receptors, tumor progression, cell adhesion
- MeSH terms
- Androgens, Cytoskeletal Proteins, Humans, Ligands, Male, Prostatic Neoplasms, Receptors, Androgen, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Two-Hybrid System Techniques, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review